ASX Share rice
Wed 05 Aug 2020 - 11:29:pm (Sydney)

PYC Share Price

PYC THERAPEUTICS LIMITEDPYCPharmaceuticals, Biotechnology & Life Sciences

PYC Company Information


PYC Therapeutics Limited





GIC Industry:


GIC Sub Industry:



Harry Perkins Institute Nedlands WA Australia 6009


61 8 6151 0992

Chief Strategy Officer & Director:

Dr. Rohan Hockings J.D., MBBS (Hons.), G.D.L.P

CEO & Director:

Mr. Douglas Huey

Company Sec. & CFO:

Mr. Kevin Hart B.Com., F.C.A., B.Com, FCA

Chief Scientific Officer:

Dr. Katrin Hoffmann

Chief Bus. Officer:

Mr. Kaggen Ausma

Company Overview:

PYC Therapeutics Limited provides drug discovery research and development services utilizing Phylomer peptide libraries and proprietary screening capabilities in Australia. The company's Phylomer libraries contain various peptides that represent a source of biologically active drug leads for a range of intracellular and extracellular disease targets. It develops next generation intracellular biological therapeutics, including its own preclinical Myc, STAT 5, and YB1 oncology inhibitor payloads using its proprietary cell penetrating functional penetrating Phylomers. The company has approximately 12 patent families comprising multiple granted/allowed patents in the United States and Australia, which cover methods of making the Phylomer libraries; methods of screening them and composition-of-matter claims for Phylomer libraries; and individual Phylomer peptides discovered for therapeutic and diagnostic applications. It has a research and development collaboration with Ramot. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

PYC Share Price Information

Shares Issued:


Market Capitalisation:


Earnings per Share:


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


PYC CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


PYC Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Income Tax Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


PYC Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


PYC Share Price History

PYC News

13 Jul, 2020
A look at the shareholders of PYC Therapeutics Limited (ASX:PYC) can tell us which group is most powerful. Insiders...
04 Mar, 2020
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
11 Oct, 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...